U.S. Markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
42.71-1.14 (-2.60%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 5815.35M
Enterprise Value 3668.84M
Trailing P/E -39.51
Forward P/E 1-46.93
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)20.52
Price/Book (mrq)3.13
Enterprise Value/Revenue 316.83
Enterprise Value/EBITDA 6-21.75

Financial Highlights

Fiscal Year
Fiscal Year Ends Sep 30, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -51.85%
Operating Margin (ttm)-82.51%
Management Effectiveness
Return on Assets (ttm)-7.35%
Return on Equity (ttm)-7.74%
Income Statement
Revenue (ttm)39.73M
Revenue Per Share (ttm)2.09
Quarterly Revenue Growth (yoy)-46.30%
Gross Profit (ttm)88.27M
EBITDA -30.75M
Net Income Avi to Common (ttm)-20.6M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)192.01M
Total Cash Per Share (mrq)10.06
Total Debt (mrq)641k
Total Debt/Equity (mrq)0.24
Current Ratio (mrq)18.53
Book Value Per Share (mrq)13.66
Cash Flow Statement
Operating Cash Flow (ttm)-6.78M
Levered Free Cash Flow (ttm)1.97M

Trading Information

Stock Price History
Beta 0.78
52-Week Change 367.69%
S&P500 52-Week Change 316.52%
52 Week High 345.74
52 Week Low 322.17
50-Day Moving Average 341.49
200-Day Moving Average 334.91
Share Statistics
Avg Vol (3 month) 3200.66k
Avg Vol (10 day) 3169.78k
Shares Outstanding 519.09M
Float 13.21M
% Held by Insiders 125.49%
% Held by Institutions 168.65%
Shares Short 31.2M
Short Ratio 35.57
Short % of Float 37.50%
Shares Short (prior month) 31.32M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A